Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robberecht

Showing results (581-590 of 651) with videos related to

Pageof 66
Sort By:
Neurobiology of Disease|August 24, 2013
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) miceKim A Staats, Lawrence Van Helleputte, Ashley R Jones, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 17, 2008
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degenerationKoen Poesen, Diether Lambrechts, Philip Van Damme, et al.
Molecular and Cellular Neurosciences|September 6, 2005
Synaptopodin and 4 novel genes identified in primary sensory neuronsNathalie Verpoorten, Kristien Verhoeven, Stefan Weckx, et al.
Scientific Reports|February 13, 2016
Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTDSteven Boeynaems, Elke Bogaert, Emiel Michiels, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 25, 2016
C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosisJames Rooney, Isabella Fogh, Henk-Jan Westeneng, et al.
The Lancet. Neurology|February 1, 2017
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trialVincent Meininger, Angela Genge, Leonard H van den Berg, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studiesIngemar S J Merkies, Ivo N van Schaik, Jean-Marc Léger, et al.
Neurology|January 11, 2008
Progranulin genetic variability contributes to amyotrophic lateral sclerosisK Sleegers, N Brouwers, S Maurer-Stroh, et al.
Protein Engineering, Design & Selection : PEDS|May 14, 2020
Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4VFilip Claes, Stanislav Rudyak, Angela S Laird, et al.
Neurology|May 26, 2010
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouseI Taes, A Goris, R Lemmens, et al.
Pageof 66

Showing results (581-590 of 651) with videos related to

Sort By:
Pageof 66
Neurobiology of Disease|August 24, 2013
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) miceKim A Staats, Lawrence Van Helleputte, Ashley R Jones, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 17, 2008
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degenerationKoen Poesen, Diether Lambrechts, Philip Van Damme, et al.
Molecular and Cellular Neurosciences|September 6, 2005
Synaptopodin and 4 novel genes identified in primary sensory neuronsNathalie Verpoorten, Kristien Verhoeven, Stefan Weckx, et al.
Scientific Reports|February 13, 2016
Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTDSteven Boeynaems, Elke Bogaert, Emiel Michiels, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 25, 2016
C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosisJames Rooney, Isabella Fogh, Henk-Jan Westeneng, et al.
The Lancet. Neurology|February 1, 2017
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trialVincent Meininger, Angela Genge, Leonard H van den Berg, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studiesIngemar S J Merkies, Ivo N van Schaik, Jean-Marc Léger, et al.
Neurology|January 11, 2008
Progranulin genetic variability contributes to amyotrophic lateral sclerosisK Sleegers, N Brouwers, S Maurer-Stroh, et al.
Protein Engineering, Design & Selection : PEDS|May 14, 2020
Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4VFilip Claes, Stanislav Rudyak, Angela S Laird, et al.
Neurology|May 26, 2010
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouseI Taes, A Goris, R Lemmens, et al.
Pageof 66